Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)

DB14385ApprovedInvestigationalWithdrawnVaccines

Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) is an influenza antigen used in seasonal influenza vaccines. A seasonally-specific component of the influenza vaccine.

First approval: United States, 2009

Resolves to

Compound

UNII166D8OWM7B

What you can answer from here — as of April 02, 2025

290Drug interactionsStructured to mechanism, not free text

33Clinical trialsPhase, status and sponsor resolved per trial

3Marketed productsAcross 2 countries and 2 labellers

Which companies are running trials of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account